Expert Review of Clinical Pharmacology

Aims & Scope

Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products.

In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore.

Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing.

Furthermore the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.

Clinical Pharmacology provides an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3
2024	3.60

SJR (SCImago Journal Rank)

Year	Value
2024	1.072

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	67

Journal Rank

Year	Value
2024	4295

Journal Citation Indicator

Year	Value
2024	1341

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Polypharmacology: drug discovery for the future

  Citation: 393

  Authors: A Srinivas, Shuxing

• Corticosteroids in brain cancer patients: benefits and pitfalls

  Citation: 284

  Authors: Jörg, Krithika, Sandra, Santosh

• Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising

  Citation: 268

  Authors: Matthew, Paul G

• Blinding and expectancy confounds in psychedelic randomized controlled trials

  Citation: 208

  Authors: Suresh D., Anna, Thomas

• Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence

  Citation: 205

  Authors: Sayeeda, Maria Teresa Villagomez, Kherie, Rita, Frank

• A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States

  Citation: 198

  Authors: Marissa, L Clark, Dhvani, Rami

• From pharmaceuticals to nutraceuticals: bridging disease prevention and management

  Citation: 182

  Authors: Patricia, Antonello, Ettore

• Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews

  Citation: 179

  Authors: Rafael G., José Carlos, Miguel Ángel, Jaime E. C.

• The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system

  Citation: 177

  Authors: Abbi L, Gregory E, Hailing

• Dupilumab for treatment of atopic dermatitis

  Citation: 174

  Authors: Marlene, Jerome, Alexandra, Macarena, Andreas

---